		<div class="wpcnt">
			<div class="wpa">
				<span class="wpa-about">Advertisements</span>
				<div class="u top_amp">
							<amp-ad width="300" height="265"
		 type="pubmine"
		 data-siteid="111265417"
		 data-section="2">
		</amp-ad>
				</div>
			</div>
		</div><p>Pfizer is doubling down on obesity treatments by spending 4.9 billion US dollars (£3.6 billion) on the development-stage drugmaker Metsera.</p>
<p>The Covid-19 vaccine and treatment maker said on Monday that it will pay 47.50 dollars (£35.20) per share in cash for each Metsera share.</p>
<p>That represents a premium of more than 42% on Metsera’s closing price on Friday.</p>
<p>Pfizer also could pay an additional 22.50 dollars (£16.67) per share depending on how Metsera’s product pipeline develops.</p>
<p>Metsera has no products on the market, but its pipeline includes four programmes in clinical development and one in mid-stage testing.</p>
<p>Demand for obesity treatments has soared in recent years, fuelled by market leaders Zepbound from Eli Lilly and Wegovy from Novo Nordisk.</p>
<p>Pfizer currently has no obesity treatments on the market but has some in clinical development.</p>
<p>Earlier this year, the company said it was ending development of a potential once-daily pill treatment before it started late-stage testing, the biggest and most expensive phase of clinical development.</p>
<p>Shares in Pfizer, based in New York, climbed 31 cents to 24.33 dollars (£18.02) before markets opened on Monday, while Metsera’s stock advanced about 60%.</p>
			<div style="padding-bottom:15px;" class="wordads-tag" data-slot-type="belowpost">
				<div id="atatags-dynamic-belowpost-68fe9a3b628bf">
					<script type="text/javascript">
						window.getAdSnippetCallback = function () {
							if ( false === ( window.isWatlV1 ?? false ) ) {
								// Use Aditude scripts.
								window.tudeMappings = window.tudeMappings || [];
								window.tudeMappings.push( {
									divId: 'atatags-dynamic-belowpost-68fe9a3b628bf',
									format: 'belowpost',
								} );
							}
						}

						if ( document.readyState === 'loading' ) {
							document.addEventListener( 'DOMContentLoaded', window.getAdSnippetCallback );
						} else {
							window.getAdSnippetCallback();
						}
					</script>
				</div>
			</div>
Discover more from London Glossy Post
Subscribe to get the latest posts sent to your email.
